Literature DB >> 14625887

Towards cellular receptors for prions.

Kil Sun Lee1, Rafael Linden, Marco Antônio M Prado, Ricardo R Brentani, Vilma R Martins.   

Abstract

Transmissible spongiform encephalopathies (TSE) are attributed to the conversion of the cellular prion protein (PrP(c)) into an abnormal isoform (PrP(sc)). This can be caused by the invasion of living organisms by infectious particles, or be inherited due to mutations on the PrP(c) gene. One of the most intriguing problems of prion biology is the inability to generate the infectious agent in vitro. This argues strongly that other cellular proteins besides those added in test tubes or found in cellular preparations are necessary for infection. Despite recent progress in the understanding of prion pathology, the subcellular compartments in which the interaction and conversion of PrP(c) into PrP(sc) take place are still controversial. PrP(c) interacts with various macromolecules at the cell membrane, in endocytic compartments and in the secretory pathway, all of which may play specific roles in the internalisation of PrP(sc) and conversion of PrP(c). A specific interacting protein required for the propagation of prions was originally proposed as a prion receptor, and later referred to as a ligand, a cofactor, protein X, or a partner. However, current studies indicate that PrP(c) associates with multi-molecular complexes, which mediate a variety of functions in distinct cellular compartments. It is proposed that a deeper understanding of the mechanics of such interactions, coupled to a better knowledge of the corresponding signalling pathways and ensuing cellular responses, will have a major impact on the prevention and treatment of TSE. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14625887     DOI: 10.1002/rmv.408

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  16 in total

1.  Infrared microspectroscopy: a multiple-screening platform for investigating single-cell biochemical perturbations upon prion infection.

Authors:  Alessandro Didonna; Lisa Vaccari; Alpan Bek; Giuseppe Legname
Journal:  ACS Chem Neurosci       Date:  2011-01-11       Impact factor: 4.418

2.  Unraveling the neuroprotective mechanisms of PrP (C) in excitotoxicity.

Authors:  Franc Llorens; José Antonio Del Río
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

3.  Bovine prion is endocytosed by human enterocytes via the 37 kDa/67 kDa laminin receptor.

Authors:  Etienne Morel; Thibault Andrieu; Fabrice Casagrande; Sabine Gauczynski; Stefan Weiss; Jacques Grassi; Monique Rousset; Dominique Dormont; Jean Chambaz
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

4.  Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex.

Authors:  Flavio H Beraldo; Valeriy G Ostapchenko; Fabiana A Caetano; Andre L S Guimaraes; Giulia D S Ferretti; Nathalie Daude; Lisa Bertram; Katiane O P C Nogueira; Jerson L Silva; David Westaway; Neil R Cashman; Vilma R Martins; Vania F Prado; Marco A M Prado
Journal:  J Biol Chem       Date:  2016-08-25       Impact factor: 5.157

5.  Inoculation of scrapie with the self-assembling RADA-peptide disrupts prion accumulation and extends hamster survival.

Authors:  Robert Hnasko; Cathrin E Bruederle
Journal:  PLoS One       Date:  2009-02-12       Impact factor: 3.240

6.  Phospholipase A2 inhibitors protect against prion and Abeta mediated synapse degeneration.

Authors:  Clive Bate; Mourad Tayebi; Alun Williams
Journal:  Mol Neurodegener       Date:  2010-04-08       Impact factor: 14.195

Review 7.  The cellular prion protein (PrP(C)): its physiological function and role in disease.

Authors:  Laura Westergard; Heather M Christensen; David A Harris
Journal:  Biochim Biophys Acta       Date:  2007-03-02

8.  Polyunsaturated fatty acids protect against prion-mediated synapse damage in vitro.

Authors:  Clive Bate; Mourad Tayebi; Mario Salmona; Luisa Diomede; Alun Williams
Journal:  Neurotox Res       Date:  2009-07-31       Impact factor: 3.911

9.  The cellular prion protein interacts with the tissue non-specific alkaline phosphatase in membrane microdomains of bioaminergic neuronal cells.

Authors:  Myriam Ermonval; Anne Baudry; Florence Baychelier; Elodie Pradines; Mathéa Pietri; Kimimitsu Oda; Benoît Schneider; Sophie Mouillet-Richard; Jean-Marie Launay; Odile Kellermann
Journal:  PLoS One       Date:  2009-08-04       Impact factor: 3.240

10.  Glimepiride reduces the expression of PrPc, prevents PrPSc formation and protects against prion mediated neurotoxicity in cell lines.

Authors:  Clive Bate; Mourad Tayebi; Luisa Diomede; Mario Salmona; Alun Williams
Journal:  PLoS One       Date:  2009-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.